CYMBALTA - CYMBALTA - CT 2319 - English version

Has

Description

Introduction CYMBALTA 30 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 7 capsules (CIP 370 237-5) and 28 capsules (CIP 365 864-5) CYMBALTA 60 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 28 capsules (CIP 365 865-1) Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 100 capsules (CIP 570 777-3) Posted on Jun 16 2009 Active substance (DCI) duloxetine ATC Code N06AX21 Laboratory / Manufacturer LILLY CYMBALTA 30 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 7 capsules (CIP 370 237-5) and 28 capsules (CIP 365 864-5) CYMBALTA 60 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 28 capsules (CIP 365 865-1) Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 100 capsules (CIP 570 777-3) Posted on Jun 16 2009

Sujets

• Médecine

Informations

• Publié par: haute-autorite-sante-traitement-medicamenteux
• Publié le: 14 mars 2007
• Nombre de lectures: 31
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

      

   

  The legally binding text is the original French version     TRANSPARENCY COMMITTEE

 

OPINION   14 March 2007         CYMBALTA 30 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 7 capsules (CIP 370 237-5) and 28 capsules (CIP 365 864-5)   CYMBALTA 60 mg, gastroresistant capsule Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 28 capsules (CIP 365 865-1) Polyvinylchloride (PVC), polyethylene (PE) and polychlorotrifluoroethylene (PCTFE) blister pack(s) sealed with an aluminium foil, containing 100 capsules (CIP 570 777-3)   Applicant : LILLY   Duloxetine   List I   Date of the Marketing Authorisations (centralised procedure): Treatment of major depressive episodes (i.e. characteristic symptoms) - 17 December 2004 Treatment of diabetic peripheral neuropathic pain in adults - 4 July 2005     Reason for request:  Inclusion of CYMBALTA 30 mg (B/7, B/28) and CYMBALTA 60 mg (B/28 and B/100) on the list of medicines approved for use by hospitals  Inclusion of CYMBALTA 30 mg (B/7 and B/28) and CYMBALTA 60 mg (B/28) on the list of medicines reimbursed by National Insurance                               Health Technology Assessment Division

 

1